Incidence and risk of xerosis with targeted anticancer therapies

Johannah Valentine1, Viswanath Reddy Belum2, Juanita Duran3

  • 1Department of Dermatology, Naval Medical Center San Diego, San Diego, California.

Abstract

Insights

Targeted cancer therapies significantly increase the risk of xerosis (dry skin). This systematic review found a 17.9% incidence, highlighting the need for early patient counseling and treatment to maintain quality of life.

Area of Science:

  • Oncology
  • Dermatology
  • Clinical Pharmacology

Background:

  • Targeted cancer therapies are associated with xerosis (dry skin).
  • The precise incidence and relative risk of xerosis from these treatments remain unclear.

Purpose of the Study:

  • To systematically review and meta-analyze clinical trials.
  • To determine the incidence and risk of xerosis in patients receiving anticancer drugs.

Main Methods:

  • Searched PubMed, Web of Science, and ASCO abstracts (1966-2013).
  • Included clinical trials involving 58 targeted anticancer agents.
  • Utilized random or fixed effects models for results calculation.

Main Results:

  • Overall incidence of xerosis was 17.9% (95% CI: 15.6-20.4%).
  • High-grade xerosis incidence was 1.0% (95% CI: 0.9-1.5%).
  • The risk of developing any-grade xerosis was 2.99 (95% CI: 2.0-4.3), varying by drug.

Conclusions:

  • Patients on targeted therapies face a significant risk of xerosis.
  • Xerosis reporting may be inconsistent.
  • Early patient counseling and treatment are crucial for managing xerosis, preventing dose reduction, and preserving quality of life.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.9K
Cancer Therapies02:49

Cancer Therapies

3.0K
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.6K
Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
75